AzTrials
AzTrials

Spinal Cord InjuriesNCT05542238

The Effect of Acute Exercise on Cardiac Autonomic, Cerebrovascular, and Cognitive Function in Spinal Cord Injury

A study testing One bout of moderate-intensity sub-maximal aerobic exercise in people with Spinal Cord Injuries and Cardiovascular Abnormalities, run by State University of New York at Buffalo at 1 site in United States.

Terminated

Stopped early. The study ended before it was planned to and will not resume.

Official record
Search all trials

Trial summary

The aims of this proposal are to: 1) investigate whether individuals with spinal cord injury (SCI) demonstrate cardiac autonomic, cerebrovascular, and cognitive dysfunctions compared to non-injured age- and sex-matched controls in the following conditions: supine rest and head-up tilt/face-cooling test; 2) examine if… Read more about this study

Who is it for?
Ages 18 to 55 yearsHealthy volunteers can take part
What is being tested?
One bout of moderate-intensity sub-maximal aerobic exercise
Could I receive a placebo?
No, everyone receives an active treatment
How many people
6 participants
Where
1 siteUnited States
Study dates
6 Sep 2022to 18 Dec 2024
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 55 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • Spinal cord injury group:
  • Males or females with chronic SCI (i.e. at least 6 months after the initial injury)
  • International Standard for Neurological Classification of SCI (ISNCSCI) A-D
  • Neurological level of injury C6 or below
  • 18-55 years old
  • Proficient in English
Show all 12Show fewer
  • Able to detect middle cerebral artery blood velocity (MCAv) and/or posterior cerebral artery blood velocity (PCAv) signals through TCD
  • Non-injured controls:
  • Males or females without SCI
  • 18-55 years old
  • Proficient in English
  • Able to detect MCAv and/or PCAv signals through TCD

Who cannot join

  • Cardiovascular, pulmonary or respiratory diseases, or diabetes mellitus, any other diseases/disorders affecting cardiac autonomic nervous system, such as glaucoma and attention deficit hyperactivity disorder (ADHD)
  • Color Blindness
  • Pregnancy

Trial locations and contacts

1 site in 1 country.

United States1 site
  • Department of Rehabilitation Sciences at University at Buffalo

    Buffalo, New York, 14214

Other trials in United States

About this study

Official title: The Effect of Acute Exercise on Cardiac Autonomic, Cerebrovascular, and Cognitive Function in Spinal Cord Injury: a Pilot Study

The aims of this proposal are to: 1) investigate whether individuals with spinal cord injury (SCI) demonstrate cardiac autonomic, cerebrovascular, and cognitive dysfunctions compared to non-injured age- and sex-matched controls in the following conditions: supine rest and head-up tilt/face-cooling test; 2) examine if autonomic completeness/ incompleteness, physical activity, and psychological distress are predictors for dysfunctions during supine rest and head-up tilt/face cooling conditions in SCI individuals; 3) examine if one bout of moderate-intensity aerobic exercise temporarily improves cardiac autonomic and cerebrovascular functions and thereby improves cognition when in supine rest and head- up tilt/face cooling conditions. The study will include an initial visit and an experimental visit to our lab. Three groups of participants will be included in this study: Group 1, SCI with acute exercise; group 2, SCI with rest-control; and group 3, age- and sex-matched non-injured individuals. Cardiovascular variables, such as heart rate variability, blood pressure variability, and cerebrovascular variables, such as cerebral blood flow velocity and oxygenated hemoglobin, and cognitive performance will be examined. The investigator hypothesizes that individuals with SCI will have impaired cardiac autonomic, cerebrovascular, and cognitive functions compared to the non-injured controls, and an acute exercise can improve those functions. Autonomic completeness/incompleteness, physical activity, and psychological distress are significant factors that predict cardiac autonomic, cerebrovascular, and cognitive functions in individuals with SCI.

Being tested
One bout of moderate-intensity sub-maximal aerobic exercise
Medical subject headings
Spinal Cord Injuries, Cardiovascular Abnormalities, Cerebrovascular Disorders, Cognitive Dysfunction

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • One bout of moderate-intensity sub-maximal aerobic exerciseBehavioural

    The intervention is a 20-min acute exercise using arm ergometer

Study groups in NCT05542238
Study groupRoleWhat they receive
CONActive comparatorAge-and sex-matched healthy controls with exercise intervention
Receives: Behavioral: One bout of moderate-intensity sub-maximal aerobic exercise
SCIExperimentalIndividuals with spinal cord injury
Receives: Behavioral: One bout of moderate-intensity sub-maximal aerobic exercise

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Cardiac sympathetic function

    Low frequency component of blood pressure variability in mmHg^2

    Measured: During baseline pre the 20-min acute exercise

  2. Cardiac parasympathetic function

    High frequency component of heart rate variability in mm^2

    Measured: During baseline pre the 20-min acute exercise

  3. Cardiac sympathetic function

    Low frequency component of blood pressure variability in mmHg^2

    Measured: During face-cooling test pre the 20-min acute exercise

  4. Cardiac parasympathetic function

    High frequency component of heart rate variability in mm^2

    Measured: During face-cooling test pre the 20-min acute exercise

  5. Cardiac sympathetic function

    Low frequency component of blood pressure variability in mmHg^2

    Measured: During head-up tilt test pre the 20-min acute exercise

  6. Cardiac parasympathetic function

    High frequency component of heart rate variability in mm^2

    Measured: During head-up tilt test pre the 20-min acute exercise

  7. Cardiac sympathetic function

    Low frequency component of blood pressure variability in mmHg^2

    Measured: During cognitive tests pre the 20-min acute exercise

  8. Cardiac parasympathetic function

    High frequency component of heart rate variability in mm^2

    Measured: During cognitive tests pre the 20-min acute exercise

  9. Cardiac sympathetic function

    Low frequency component of blood pressure variability in mmHg^2

    Measured: During baseline post the 20-min acute exercise

  10. Cardiac sympathetic function

    Low frequency component of blood pressure variability in mmHg^2

    Measured: During face-cooling post the 20-min acute exercise

  11. Cardiac parasympathetic function

    High frequency component of heart rate variability in mm^2

    Measured: During face-cooling post the 20-min acute exercise

  12. Cardiac sympathetic function

    Low frequency component of blood pressure variability in mmHg^2

    Measured: During head-up tilt test post the 20-min acute exercise

  13. Cardiac parasympathetic function

    High frequency component of heart rate variability in mm^2

    Measured: During head-up tilt test post the 20-min acute exercise

  14. Cardiac sympathetic function

    Low frequency component of blood pressure variability in mmHg^2

    Measured: During cognitive tests post the 20-min acute exercise

  15. Cardiac parasympathetic function

    High frequency component of heart rate variability in mm^2

    Measured: During cognitive tests post the 20-min acute exercise

  16. Cerebrovascular functions

    Assessed by the middle and posterior cerebral artery velocity in centimeters per second

    Measured: During baseline pre the 20-min acute exercise

  17. Cerebrovascular functions

    Assessed by the middle and posterior cerebral artery velocity in centimeters per second

    Measured: During the face-cooling test pre the 20-min acute exercise

  18. Cerebrovascular functions

    Assessed by the middle and posterior cerebral artery velocity in centimeters per second

    Measured: During the head-up tilt test pre the 20-min acute exercise

  19. Cerebrovascular functions

    Assessed by the middle and posterior cerebral artery velocity in centimeters per second

    Measured: During the cognitive tests pre the 20-min acute exercise

  20. Cerebrovascular functions

    Assessed by the middle and posterior cerebral artery velocity in centimeters per second

    Measured: During baseline post the 20-min acute exercise

  21. Cerebrovascular functions

    Assessed by the middle and posterior cerebral artery velocity in centimeters per second

    Measured: During the face-cooling test post the 20-min acute exercise

  22. Cerebrovascular functions

    Assessed by the middle and posterior cerebral artery velocity in centimeters per second

    Measured: During the head-up tilt test post the 20-min acute exercise

  23. Cerebrovascular functions

    Assessed by the middle and posterior cerebral artery velocity in centimeters per second

    Measured: During the cognitive tests post the 20-min acute exercise

  24. Cerebral oxygenation level

    Cerebral oxygenated hemoglobin in unknown unit

    Measured: Change from baseline to the cognitive tests pre the 20-min acute exercise

  25. Cerebral oxygenation level

    Cerebral oxygenated hemoglobin in unknown unit

    Measured: Change from baseline to the cognitive tests post the 20-min acute exercise

  26. Cognitive function

    Reaction time in second

    Measured: During baseline pre the 20-min acute exercise

  27. Cognitive function

    Error made during the cognitive test in number

    Measured: During baseline pre the 20-min acute exercise

  28. Cognitive function

    Reaction time in second

    Measured: During head-up tilt pre the 20-min acute exercise

  29. Cognitive function

    Error made during the cognitive test in number

    Measured: During head-up tilt pre the 20-min acute exercise

  30. Cognitive function

    Reaction time in second

    Measured: During baseline post the 20-min acute exercise

  31. Cognitive function

    Error made during cognitive test in number

    Measured: During baseline post the 20-min acute exercise

  32. Cognitive function

    Reaction time in second

    Measured: During head-up tilt post the 20-min acute exercise

  33. Cognitive function

    Error made during the cognitive test in number

    Measured: During head-up tilt post the 20-min acute exercise

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted15 Sep 2022
  2. Study start6 Sep 2022
  3. Primary completion18 Dec 2024
  4. Study completion18 Dec 2024

Why it stopped: We have enrolled all the required participants for this pilot study.

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Not applicable
Intervention model
Factorial
Masking
None (open label)
Enrolment
6 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05542238
Sponsor's protocol ID
STUDY00006517-Pilot
Status last verified
Mar 2025
First submitted
7 Sep 2022
Last updated
6 Mar 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing One bout of moderate-intensity sub-maximal aerobic exercise in people with Spinal Cord Injuries and Cardiovascular Abnormalities, run by State University of New York at Buffalo at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 12 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: stopped early, as of the sponsor's last update on 6 Mar 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study was stopped early (reason given: We have enrolled all the required participants for this pilot study.). Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Cardiac sympathetic function (time frame: During baseline pre the 20-min acute exercise). The study lists 33 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 6 Mar 2025; AzTrials last refreshed its copy on 8 Nov 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in